HoxB5 transcriptionally regulates the vascular endothelial growth factor receptor KDR/flk-1 in vitro and in vivo

被引：0
|
作者：
Wu, YX [1 ]
Patterson, C [1 ]
机构：
[1] Univ N Carolina, Carolina Cardiovasc Biol Ctr, Chapel Hill, NC 27515 USA
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2002年 / 22卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
31
引用
收藏
页码：A6 / A6
页数：1
相关论文
共 50 条
  • [21] Inhibition of the vascular endothelial growth factor (VEGF) receptor (KDR/Flk-1) decreases alveolarization and alters vascular growth and structure in the developing rat lung
    Jakkula, M
    Le Cras, TD
    Gebb, SA
    Hirth, KP
    Tuder, RM
    Voelkel, NF
    Abman, SH
    [J]. PEDIATRIC RESEARCH, 2000, 47 (04) : 71A - 71A
  • [22] Expression and distribution of vascular endothelial growth factor receptor Flk-1 in the rat pituitary
    Vidal, S
    Lloyd, RV
    Moya, L
    Scheithauer, BW
    Kovacs, K
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2002, 50 (04) : 533 - 540
  • [23] Expression of vascular endothelial growth factor receptor Flk-1 in canine mammary tumours
    Restucci, B
    Borzacchiello, G
    Maiolino, P
    Martano, M
    Paciello, O
    Papparella, S
    [J]. JOURNAL OF COMPARATIVE PATHOLOGY, 2004, 130 (2-3) : 99 - 104
  • [24] Regulation of vascular endothelial growth factor receptor-2 (Flk-1) expression in vascular endothelial cells
    Pepper, MS
    Mandriota, SJ
    [J]. EXPERIMENTAL CELL RESEARCH, 1998, 241 (02) : 414 - 425
  • [25] Emodin inhibits vascular endothelial growth factor-A-induced angiogenesis by blocking receptor-2 (KDR/Flk-1) phosphorylation
    Kwak, HJ
    Park, MJ
    Park, CM
    Moon, SI
    Yoo, DH
    Lee, HC
    Lee, SH
    Kim, MS
    Lee, HW
    Shin, WS
    Park, IC
    Rhee, CH
    Hong, SI
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (11) : 2711 - 2720
  • [26] The vascular endothelial growth factor receptor KDR/Flk-1 is a major regulator of malignant ascites formation in the mouse hepatocellular carcinoma model
    Yoshiji, H
    Kuriyama, S
    Hicklin, DJ
    Huber, J
    Yoshii, J
    Ikenaka, Y
    Noguchi, R
    Nakatani, T
    Tsujinoue, H
    Fukui, H
    [J]. HEPATOLOGY, 2001, 33 (04) : 841 - 847
  • [27] Heterodimers of placenta growth factor vascular endothelial growth factor - Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR
    Cao, YH
    Chen, H
    Zhou, L
    Chiang, MK
    AnandApte, B
    Weatherbee, JA
    Wang, YD
    Fang, FY
    Flanagan, JG
    Tsang, MLS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (06) : 3154 - 3162
  • [28] Expression of vascular endothelial growth factor and receptor flk-1 in colon cancer liver metastases
    Cheng, J
    Slavin, R
    Gallagher, J
    Zhu, GJ
    O'Rourke, R
    Biehl, T
    Swanstrom, L
    Hansen, P
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2003, 197 (03) : S76 - S77
  • [29] Oroxylin A inhibits angiogenesis through blocking vascular endothelial growth factor-induced KDR/Flk-1 phosphorylation
    Gao, Ying
    Lu, Na
    Ling, Yun
    Chen, Yan
    Wang, Ling
    Zhao, Qing
    Qi, Qi
    Liu, Wei
    Zhang, Haiwei
    You, Qidong
    Guo, Qinglong
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (05) : 667 - 675
  • [30] PLACENTA GROWTH-FACTOR - POTENTIATION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR BIOACTIVITY, IN-VITRO AND IN-VIVO, AND HIGH-AFFINITY BINDING TO FLT-1 BUT NOT TO FLK-1/KDR
    PARK, JE
    CHEN, HH
    WINER, J
    HOUCK, KA
    FERRARA, N
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (41) : 25646 - 25654
12345